Boehringer Ingelheim Pharmaceuticals, Inc.
Boehringer Ingelheim Pharmaceuticals, Inc. is listed as the manufacturer on 9 FDA drug label records covering 8 distinct active ingredients predominantly human prescription drug products.
About Boehringer Ingelheim Pharmaceuticals, Inc.
Boehringer Ingelheim Pharmaceuticals, Inc. is named as the labeler on 9 FDA drug label records. Its catalogue spans 8 distinct active ingredients, led by LINAGLIPTIN AND METFORMIN HYDROCHLORIDE, ADALIMUMAB-ADBM, EMPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE, EMPAGLIFLOZIN, LINAGLIPTIN, METFORMIN HYDROCHLORIDE. Most of these labels are human prescription drug products. Labelling across this portfolio most often references: type diabetes, synjardy synjardy, improve glycemic, kidney disease, adult patients, indicated adjunct, control adults, combination empagliflozin. Use the table below to identify a specific product, then open it for full indications, dosage and warnings as filed with the FDA.
Active ingredients in this portfolio
Dosage forms and routes
| Dosage form | Products | Route | Products |
|---|---|---|---|
| — | — | ORAL | 7 |
| — | — | RESPIRATORY (INHALATION) | 1 |
| — | — | — | — |
| — | — | — | — |
| — | — | — | — |
| — | — | — | — |
FDA drug products from Boehringer Ingelheim Pharmaceuticals, Inc.
| Brand name | Generic | Type | Route |
|---|---|---|---|
| Cyltezo | ADALIMUMAB-ADBM | HUMAN PRESCRIPTION DRUG | |
| HERNEXEOS | ZONGERTINIB | HUMAN PRESCRIPTION DRUG | ORAL |
| JASCAYD | NERANDOMILAST | HUMAN PRESCRIPTION DRUG | ORAL |
| Jentadueto | LINAGLIPTIN AND METFORMIN HYDROCHLORIDE | HUMAN PRESCRIPTION DRUG | ORAL |
| Jentadueto XR | LINAGLIPTIN AND METFORMIN HYDROCHLORIDE | HUMAN PRESCRIPTION DRUG | ORAL |
| Spiriva Respimat | TIOTROPIUM BROMIDE INHALATION SPRAY | HUMAN PRESCRIPTION DRUG | RESPIRATORY (INHALATION) |
| Synjardy | EMPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | HUMAN PRESCRIPTION DRUG | ORAL |
| Synjardy XR | EMPAGLIFLOZIN, METFORMIN HYDROCHLORIDE | HUMAN PRESCRIPTION DRUG | ORAL |
| Trijardy XR | EMPAGLIFLOZIN, LINAGLIPTIN, METFORMIN HYDROCHLORIDE | HUMAN PRESCRIPTION DRUG | ORAL |
Frequently asked questions
How many FDA drug products does Boehringer Ingelheim Pharmaceuticals, Inc. make?
9 FDA drug label records name Boehringer Ingelheim Pharmaceuticals, Inc. as the manufacturer, covering 8 distinct active ingredients.
What active ingredients does Boehringer Ingelheim Pharmaceuticals, Inc. produce?
The most frequent active ingredients in this portfolio are LINAGLIPTIN AND METFORMIN HYDROCHLORIDE, ADALIMUMAB-ADBM, EMPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE, EMPAGLIFLOZIN, LINAGLIPTIN, METFORMIN HYDROCHLORIDE, EMPAGLIFLOZIN, METFORMIN HYDROCHLORIDE.
Are Boehringer Ingelheim Pharmaceuticals, Inc. products prescription or over-the-counter?
The largest share of this company’s labels are human prescription drug products; check each product page for its own marketing status.
Does this page list prices or where to buy?
No. This is a labelling reference built from FDA data. It does not sell, price or recommend any medicine.
Labelling data reproduced from FDA Structured Product Labelling for identification only. This site does not sell, price or recommend any medicine.